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Differential diagnoses of cardiac masses include primary benign and malignant neoplasms, secondary neoplasms,
and non-neoplastic masses, such as thrombi. Owing to different therapeutic approaches and the way these affect
the prognosis, the early and correct diagnostic determination of the etiology of a cardiac mass is of utmost
importance and essential for the appropriate management of patients.
We report a case of a 52-year-old woman with a left ventricular mass in the setting of a recent Mycoplasma pneumoniae
infection and a medical history of cutaneous T-cell lymphoma and hypereosinophilia. Imaging findings were consistent
with both an infiltrative process of the lymphoma and a cardiac thrombus. An estimated very high risk for embolization
led to the indication for open-heart surgery for the removal of the cardiac mass. Histopathological examination confirmed
the presence of a thrombus; there were no signs of malignancy. The patient was discharged 11 days after surgery in good
general condition and is now in outpatient care for follow-up and further management.
This case highlights possible challenges in the diagnostic assessment of cardiac masses and their management in a
patient with several underlying diseases and a complex medical history.
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Primary cardiac neoplasms are rare, with an average
frequency of approximately 0.021% in autopsy series [1].
By comparison, secondary (metastatic) neoplasms are
more common, found in 9.1% of patients with malignant
diseases in an autopsy study [2]. Cardiac metastatic in-
volvement is mainly observed in pleural mesotheliomas,
melanomas, carcinomas of the lung, breast, and ovaries,
and in lymphomyeloproliferative neoplasms [2].
The most frequently diagnosed cardiac masses are no
neoplasms, but tumor-like lesions, such as cardiac thrombi.
Intracardiac thrombi can mimic neoplasms, and despite
modern imaging techniques differentiation can be difficult
[3]. Owing to different therapeutic approaches and the way
these affect the prognosis, the early and correct diagnostic* Correspondence: claudia.oeser@meduniwien.ac.at
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importance and essential for the appropriate management
of patients.
Systemic thromboembolism constitutes a much feared
complication of left ventricular thrombi, especially in
cases where it triggers cerebral events. Protrusion and
mobility of a thrombus are indicators for an increased
risk of embolism [4].
Anticoagulation therapy has been shown to be effective
in reducing the risk for embolic events after thrombus
formation in patients with myocardial infarction [5].
Anticoagulation therapy is currently the mainstay in the
treatment of cardiac thrombi. However, because of the
great variety of possible underlying causes and processes,
a general therapeutic recommendation is lacking [6].
Thrombolysis [6] or surgical treatment [6,7] might be
considered in high risk patients. Careful evaluation of risks
and benefits is necessary for both interventions [6,7].his is an Open Access article distributed under the terms of the Creative
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of post-treatment embolism compared with anticoagula-
tion therapy alone [7]. This supports the assumption that
surgical intervention may be beneficial in certain circum-
stances [6].
Case presentation
A 52-year-old woman from Austria sought medical at-
tention for a dry cough, severe shortness of breath, and
increasing fatigue during her holiday trip to Australia.
Symptoms first occurred four days before admission and
about two weeks after long-haul air travel. Additionally,
the patient presented with new-onset chest pain.
The patient was known to have had non-Hodgkin
lymphoma (NHL), type cutaneous T-cell lymphoma
(CTCL), subtype Sézary syndrome, for about three
years. After histopathological confirmation of lymph
node infiltration (stage IVA) one year ago, the patient
received six cycles of chemotherapy with liposomal
Doxorubicin. This treatment was followed by extracor-
poreal photophoresis; the last cycle was administered
two weeks before she traveled to Australia. Additionally,
interferon-alpha therapy was started. However, because of
the occurrence of retinitis and vision disorders, adminis-
tration was stopped two weeks before the patient’s jour-
ney. Her medical history also revealed hypereosinophilia
and hyperlipidemia. At the start of the journey, the patient
hadn’t been on any medication.
On first admission the patient presented with symp-
toms and signs of congestive heart failure. Physical
examination showed hypotension and tachycardia (heart
rate around 110 bpm). The patient had no fever, and
oxygen saturation was within the normal range. On
auscultation, no cardiac murmur was noted, but bilateral
basal crackles were heard. A full blood count showed mild
anemia (hemoglobin 113 g/l) and a total white cell count
of 35.4×109/l, with an increase in neutrophils (11.9×109/l),
lymphocytes (18×109/l), eosinophils (4.4×109/l), and baso-
phils (0.5×109/l). Further laboratory investigations revealed
hypoalbuminemia (24 g/l) and raised concentrations of
troponin I (0.23 μg/l), lactate dehydrogenase (319 U/l),
CRP (34 mg/l), and BNP (2103 pg/ml). The troponin I
level stayed on the same level for the first 24 hours after
hospitalization. The following day, the troponin level was
falling (0.177 μg/l). An electrocardiogram showed sinus
rhythm with ST-segment depression and T-wave inversion
in the inferolateral leads. Initial clinical differential diagno-
ses included non-ST elevation myocardial infarction
(NSTEMI), viral myocarditis, and lower respiratory tract
infection. The patient was started on acetylsalicylic acid
and enoxaparin, as well as on benzylpenicillin and
doxycycline. A chest X-ray detected bilateral intersti-
tial edema and basal plate atelectasis. A computed
tomography pulmonary angiogram (CTPA) ruled outpulmonary embolism but identified bilateral pleural
effusions and multiple small non-specific nodules in
both lungs, on a background of diffuse ground-glass
change. Transthoracic echocardiography (TTE) found
a cardiac mass located in the apical region of the left
ventricle. The subjacent apical segments of the left
ventricle moved poorly. Initially an infiltrative process
in the endocardium and adjacent myocardium with
inflammatory or malignant cells was suspected, as a
result of cardiac involvement by the lymphoma. After
these diagnostic findings, anticoagulation and antibi-
otics were stopped.
Because the need for a cardiothoracic intervention was
highly probable, the patient was referred to a tertiary
care center for further diagnostic work-up and treatment
the day after first admission. Computed tomography
(CT) scans of chest, abdomen, and pelvis showed the
presence of a soft tissue mass arising from the lateral left
ventricular wall, projecting into the cavity. Furthermore,
CT revealed ectasia of the ascending aorta (diameter:
about 40 mm), bilateral axillary and inguinal lymphaden-
opathy, with lymph nodes measuring up to 12 mm, and
mild to moderate hepatosplenomegaly. Cardiac findings
on magnetic resonance imaging (MRI) seemed consist-
ent with endomyocardial fibrosis of the apical left
ventricle, which was associated with a large concentric
apical thrombus (Figure 1a). A small pericardial effusion
was detected. No regional wall motion abnormality was
found. Subsequently, anticoagulation was started with
enoxaparin. Furthermore, the patient was treated with
oral prednisolone, and she responded well to forced
diuresis with furosemide. Because the positive serology
test for Mycoplasma pneumonia indicated recent infec-
tion, the previous antibiotic treatment, consisting of pi-
peracillin and tazobactam, was replaced by ceftriaxone
and azithromycin, followed by amoxicillin in combin-
ation with clavulanic acid.
At the patient’s request, she was transferred back to
Europe by air ambulance, 21 days after she was first ad-
mitted to hospital, and was hence referred to the Vienna
General Hospital. The patient was admitted with mild
to moderate dyspnea in a stable condition, complain-
ing about no other symptoms. Troponin I levels were
within the normal range. ECG showed sinus rhythm
with ST-segment depression, and T-wave inversion in
precardiac leads.
The first TTE after admission showed that the apical
third of the mildly hypertrophic left ventricle was com-
pletely filled with an intracavital mass (30×34mm),
which was suspected to be a thrombus with or without
involvement of neoplastic cells. Akinesia of the subjacent
myocardium was detected, but the ejection fraction was
calculated to be 68%. An additional echocardiographic
cine-loop shows this in more detail (see Additional file 1).
Figure 1 Cardiac MRI (T2-weighted). a: Cardiac MRI showing the thrombus filling the apex. b: Cardiac MRI showing the shrunken, free-floating, and
pedunculated thrombus, arising from the lateral wall.
Figure 2 Cardiac thrombus after surgical removal.
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visual field, cranial CT and MRI were performed. The
latter confirmed the presence of two small point-shaped
lesions, one in the right cerebellar hemisphere and one
in the right precentral gyrus, consistent with a recent
embolic/ischemic event. Five days after the initial TTE,
cardiac MRI showed that the mass had shrunk to a con-
siderably smaller size (diameter: approx. 10 mm), free-
floating and pedunculated, arising from the lateral wall
(Figure 1b). An additional echocardiographic cine-loop
shows this in more detail (see Additional file 2). In com-
bination with the diagnostic finding of the fluorine-18
fluorodeoxyglucose (F-18 FDG) positron emission tomog-
raphy/CT, the suspect hypertrophic apical region seemed
consistent with an infiltrative process of the lymphoma.
The myocardium was thickened and there was a grayish
discoloration of the tissue. The akinesia described
earlier was not detectable anymore. In the repeat TTE per-
formed one day later, the suspect hypertrophic apical
region seemed consistent with endomyocardial fibro-
sis. Echocardiographic findings leading to the picture
of endomyocardial fibrosis included the combination
of myocardial thickening, a thrombus adherent to the
endocardial surface, and enlargement of the left atrium.
The patient received anticoagulation therapy between the
imaging procedures showing reduction in size of the
intracardiac mass.
The disease course with shape change and size reduc-
tion of the intracardiac mass prompted the assumption
that the intracardiac mass was most likely a thrombus
with an estimated very high risk for embolization.
Consequently, urgent surgery was indicated. Unevent-
ful open-heart surgery using cardiopulmonary bypass
was performed through a median sternotomy. Removal of
the highly mobile left intraventricular mass was easily
achieved by access via the left atrium (Figure 2).
Histopathological examination of this tissue showedpredominantly thrombotic material consisting of lay-
ered fibrin, partly encircled by histiocytes, and addition-
ally a collagen rich scar area. After incision of the aorta,
a suspicious incisional margin involving the apical
region up to the middle of the left ventricle was identi-
fied. The margin’s boundary to the surrounding tissue
was not defined, and therefore it raised suspicion for
being a malignant infiltration. The margin was removed
as far as possible, and a biopsy of the apical region was
taken. Malignant cells were not detected on histological
evaluation.
Postoperatively performed echocardiography showed
normal left ventricular systolic function and normal wall
movement in the absence of akinetic areas. The patient
made an uneventful postoperative recovery and was
therefore discharged, 11 days after surgery and in good
general condition.
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and the patient is now in outpatient care for follow-up
and further management.
Conclusion
In most cases, TTE is the initial performed imaging
technique for the detection and diagnosis of cardiac
masses. One the one hand, TTE can provide reliable
anatomic and functional features of a detected cardiac
mass, but, on the other hand, its ability to characterize
tissue is limited. Cardiac MRI is superior in this regard
and should therefore be the diagnostic tool of choice
for the assessment of cardiac masses today [3].
For example, where ventricular thrombi are concerned,
sensitivity and specify in contrast-enhanced MRI were
highest compared with TTE and transesophageal echocar-
diography (TEE). With an overall sensitivity of only 23%
in TTE, cardiac MRI (overall sensitivity of 88%) may also
be performed in patients considered at risk for thrombus
formation without any finding on TTE [8].
In our patient, MRI was the first modality to correctly
identify the cardiac mass as a thrombus. However, the
suggested infiltrative process of lymphoma was not con-
firmed in the histopathological examination. This high-
lights the remaining difficulties in diagnostic MRI scans
of cardiac masses. Histopathological examination is es-
sential for the establishment of the correct diagnosis [9].
Thrombus formation in the left ventricle is typically
associated with left-ventricular-wall motion disorders
and impaired left ventricular function [6]. Consequently,
left-ventricular thrombosis mainly occurs in coronary
artery disease, especially as a complication after myocar-
dial infarction [10], as well as in dilated cardiomyopathy
[11], transient apical ballooning [12], and myocarditis
[13]. Thrombophilic disorders - for example, antipho-
spholipid syndrome [14] - can predispose to cardiac
thrombosis in the absence of heart disease. Cardiac in-
volvement with development of intracardiac thrombosis
is also described in the setting of systemic diseases, such
as American trypanosomiasis [15], and amyloidosis [16].
A meta-analysis by Caruso et al. [17] showed a global
thrombosis incidence of 6.4% in adult lymphoma pa-
tients. Although patients with hematologic malignancies
are known to be at an increased risk for venous throm-
bosis, 16.5% of total thrombotic events were observed in
the arterial system.
Potential mechanisms, which lead to thrombosis in
hypereosinophilia, include inhibition of anticoagulant
pathways, activation of coagulation and endothelial
damage caused by cytotoxic effects [18].
It is assumed that an association exists between
Mycoplasma pneumoniae infection and the occurrence
of arterial and venous thrombi. The underlying pathogen-
esis remains unclear, however. Mechanisms of directinvasion and mechanisms of autoimmune modulation
are under discussion. Cardiac thrombi in patients with
Mycoplasma pneumoniae infection are extremely rare [19].
In conclusion, one of the patient’s underlying diseases
or the combination of those could have put her in a hy-
percoagulable state, which resulted in thrombus forma-
tion. In hindsight, based on the clinical and diagnostic
findings including transient wall motion abnormalities,
moderate rise of troponin I levels declining after 24 hours
and ECG changes, takotsubo cardiomyopathy could also
have been a reasonable explanation for the patient’s con-
dition. This unusual case highlights possible challenges
in the diagnostic assessment of cardiac masses and their
management in patients with several underlying diseases
and a complex medical history.
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